Silence Therapeutics PLC
NASDAQ:SLN

Watchlist Manager
Silence Therapeutics PLC Logo
Silence Therapeutics PLC
NASDAQ:SLN
Watchlist
Price: 17.52 USD -1.68% Market Closed
Market Cap: 817.5m USD
Have any thoughts about
Silence Therapeutics PLC?
Write Note

Silence Therapeutics PLC
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Silence Therapeutics PLC
Long-Term Debt Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Silence Therapeutics PLC
OTC:SLNCF
Long-Term Debt
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Long-Term Debt
$75.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Long-Term Debt
ÂŁ48m
CAGR 3-Years
-8%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Long-Term Debt
ÂŁ272.3m
CAGR 3-Years
28%
CAGR 5-Years
21%
CAGR 10-Years
14%

See Also

What is Silence Therapeutics PLC's Long-Term Debt?
Long-Term Debt
0 GBP

Based on the financial report for Dec 31, 2019, Silence Therapeutics PLC's Long-Term Debt amounts to 0 GBP.

Back to Top